Cargando…
Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
Perihilar cholangiocarcinoma (PHCCA) has a poor prognosis, mainly due to diagnosis at an advanced stage. Cripto-1 functions as an oncogene and is highly expressed in several human cancers, however, its clinical application in PHCCA is poorly understood. Herein, we identified that Cripto-1 was releas...
Autores principales: | Hu, Chunxiao, Zhang, Yanli, Zhang, Mengjiao, Li, Tingting, Zheng, Xin, Guo, Qining, Zhang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380828/ https://www.ncbi.nlm.nih.gov/pubmed/34434900 http://dx.doi.org/10.3389/fonc.2021.730615 |
Ejemplares similares
-
ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma
por: Liu, Pei, et al.
Publicado: (2022) -
Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma
por: Zhang, DengYong, et al.
Publicado: (2023) -
CT-Based Radiomics Analysis for Noninvasive Prediction of Perineural Invasion of Perihilar Cholangiocarcinoma
por: Zhan, Peng-Chao, et al.
Publicado: (2022) -
Irreversible Electroporation Treatment With Intraoperative Biliary Stenting for Unresectable Perihilar Cholangiocarcinoma: A Pilot Study
por: Yang, Po-Chih, et al.
Publicado: (2021) -
Vascular Resection in Perihilar Cholangiocarcinoma
por: Serrablo, Alejandro, et al.
Publicado: (2021)